ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:

Dictionar de medicamente online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dictionar medical online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Puteti trimite articole cu tema medicala la
adresa de email

Solutie antistress!
Construieste poduri :)

Joc, Construieste podul, Cargo Bridge

Prinde pisica neagra :)
Prinde pisica neagra- Chat Noir - Flash game

Rep. DeGette Requests Meeting With President Bush On Embryonic Stem Cell Research Bill

Rep. Diana DeGette (D-Colo.) last week said she has requested a face-to-face meeting with President Bush regarding a bill (HR 810) she has co-sponsored that would expand federal funding for human embryonic stem cell research, the Denver Post reports (Mulkern, Denver Post, 6/5). Bush on Aug. 9, 2001, announced a policy that allows federal funding for embryonic stem cell research only when it uses stem cell lines created on or before that date. DeGette's bill, which was approved by the House last year, would allow federal funding for research using stem cells derived from embryos originally created for fertility treatments and willingly donated by patients. Sen. Arlen Specter (R-Pa.), sponsor of the Senate version of the bill (S 471), in October 2005 said that Senate Majority Leader Bill Frist (R-Tenn.) agreed to make consideration of the bill a priority when Congress reconvened in January 2006. Frist last month said the Senate will debate three separate bills on stem cell research, but he did not stipulate which measures would be discussed (Kaiser Daily Women's Health Policy Report, 6/2). DeGette -- during a phone interview from London, where she went to examine stem cell research efforts in the United Kingdom -- said from what she knows, none of the bills Frist is considering to bring to the Senate floor would affect HR 810. Bush has said he would veto the bill if it were passed by the Senate. "All I request is that [Bush] sit down face-to-face with me and let me try to explain the impact this bill will have on the millions of people who suffer from ... diseases," such as Parkinson's disease, Alzheimer's disease, and type 1 diabetes, DeGette said. Sen. Orrin Hatch (R-Utah), who supports HR 810, believes it is possible to obtain the 67 votes in the Senate necessary to override a presidential veto, his spokesperson Peter Carr said. However, the House last year voted 238-194 to approve the bill, short of the two-thirds majority needed to override a veto (Denver Post, 6/5).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.





Rep DeGette Cererile întâlnire cu preºedintele Bush Pe celule stem embrionare de Cercetare Bill - Rep. DeGette Requests Meeting With President Bush On Embryonic Stem Cell Research Bill - articole medicale engleza - startsanatate